LeafNLP Demos
Back to explore

Report #2865237

Received Oct 13, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
Apr 1, 2025
Onset
Apr 1, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2——

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Late 2nd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 2020). In APR-2025, the patient received the 2nd dose of Shingrix. In APR-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Late 2nd dose). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt date: 02-OCT-2025 Patient stated got 1 shot of Shingrix in 2020 and forgot to get a second. She then got a second shot in April of this year 2025. Does she need another i know it says to not restart the schedule, but it's been 5 years. The HCP did not provide the specific dates for the vaccines, only said 1st dose in 2020 and 2nd dose in Apr 2025. The batch number was not provided and a request for this information has been made.